Interferon regulatory factor-1 (IRF-1) is a mediator for interferon-γ induced attenuation of telomerase activity and human telomerase reverse transcriptase (hTERT) expression

[1]  R. Schlegel,et al.  Cervical epithelial cells transduced with the papillomavirus E6/E7 oncogenes maintain stable levels of oncoprotein expression but exhibit progressive, major increases in hTERT gene expression and telomerase activity. , 2002, The American journal of pathology.

[2]  C J L M Meijer,et al.  The causal relation between human papillomavirus and cervical cancer. , 2002, Journal of clinical pathology.

[3]  T. Veldman,et al.  Transcriptional Activation of the Telomerase hTERT Gene by Human Papillomavirus Type 16 E6 Oncoprotein , 2001, Journal of Virology.

[4]  D. Crowe,et al.  Rb and E2F-1 regulate telomerase activity in human cancer cells. , 2001, Biochimica et biophysica acta.

[5]  D. Grandér,et al.  Interferon alpha down-regulates telomerase reverse transcriptase and telomerase activity in human malignant and nonmalignant hematopoietic cells. , 2000, Blood.

[6]  D. Flint,et al.  A novel role for IRF-1 as a suppressor of apoptosis , 2000, Oncogene.

[7]  L. Blatt,et al.  The effects of interferon on the expression of human papillomavirus oncogenes. , 2000, The Journal of general virology.

[8]  J. Yim,et al.  The Wilms' Tumor 1 Tumor Suppressor Gene Represses Transcription of the Human Telomerase Reverse Transcriptase Gene* , 1999, The Journal of Biological Chemistry.

[9]  W. Hahn,et al.  Inhibition of telomerase limits the growth of human cancer cells , 1999, Nature Medicine.

[10]  M. Robinson,et al.  Telomere shortening and apoptosis in telomerase-inhibited human tumor cells. , 1999, Genes & development.

[11]  H. Nawata,et al.  Telomerase activity in myeloma cells is closely related to cell cycle status, but not to apoptotic signals induced by interferon-alpha. , 1999, Leukemia & lymphoma.

[12]  Y. Furukawa,et al.  Interferon-α repressed telomerase along with G1-accumulation of Daudi cells , 1999 .

[13]  J. Shay,et al.  Role of telomerase in cellular proliferation and cancer , 1999, Journal of cellular physiology.

[14]  T. Taniguchi,et al.  Loss of transcription factor IRF-1 affects tumor susceptibility in mice carrying the Ha-ras transgene or nullizygosity for p53. , 1999, Genes & development.

[15]  T. Akaike,et al.  IRF-1 is an essential mediator in IFN-gamma-induced cell cycle arrest and apoptosis of primary cultured hepatocytes. , 1999, Biochemical and biophysical research communications.

[16]  Jhingook Kim,et al.  Intraperitoneal gene therapy with adenoviral-mediated p53 tumor suppressor gene for ovarian cancer model in nude mouse , 1999, Cancer Gene Therapy.

[17]  R. Dalla‐Favera,et al.  Direct activation of TERT transcription by c-MYC , 1999, Nature Genetics.

[18]  J. Fujimoto,et al.  Expression of Telomerase Catalytic Component, Telomerase Reverse Transcriptase, in Human Gastric Carcinomas , 1998, Japanese journal of cancer research : Gann.

[19]  T. Taniguchi,et al.  Functionally inactivating point mutation in the tumor‐suppressor IRF‐1 gene identified in human gastric cancer , 1998, International journal of cancer.

[20]  G. Hannon,et al.  Myc activates telomerase. , 1998, Genes & development.

[21]  C. Greider.  Telomerase activity, cell proliferation, and cancer. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[22]  C B Harley,et al.  Telomerase catalytic subunit homologs from fission yeast and human. , 1997, Science.

[23]  P. Fitzpatrick,et al.  Interferon-γ Modulates a p53-independent Apoptotic Pathway and Apoptosis-related Gene Expression* , 1997, The Journal of Biological Chemistry.

[24]  J. Shay,et al.  A survey of telomerase activity in human cancer. , 1997, European journal of cancer.

[25]  J. Langmore,et al.  Long G Tails at Both Ends of Human Chromosomes Suggest a C Strand Degradation Mechanism for Telomere Shortening , 1997, Cell.

[26]  J. Darnell,et al.  Interactions between STAT and non-STAT proteins in the interferon-stimulated gene factor 3 transcription complex , 1996, Molecular and cellular biology.

[27]  J. Darnell,et al.  Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[28]  P. Boukamp,et al.  Telomerase activity in the regenerative basal layer of the epidermis inhuman skin and in immortal and carcinoma-derived skin keratinocytes. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J. Shay,et al.  The reactivation of telomerase activity in cancer progression. , 1996, Trends in genetics : TIG.

[30]  J. Shay.  Aging and cancer: are telomeres and telomerase the connection? , 1995, Molecular medicine today.

[31]  T. Taniguchi,et al.  An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes , 1995, Nature.

[32]  N. Young,et al.  Nitric oxide suppression of human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha. , 1995, The Journal of clinical investigation.

[33]  C. Harley,et al.  Evidence for a critical telomere length in senescent human fibroblasts. , 1995, Experimental cell research.

[34]  T. Taniguchi,et al.  Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1 , 1994, Cell.

[35]  P. Lengyel.  Tumor-suppressor genes: news about the interferon connection. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[36]  M Kitagawa,et al.  Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2 , 1993, Science.

[37]  al. et,et al.  Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia , 1993, Science.

[38]  J. Farber,et al.  A collection of mRNA species that are inducible in the RAW 264.7 mouse macrophage cell line by gamma interferon and other agents , 1992, Molecular and cellular biology.

[39]  M. Schiffman,et al.  Recent progress in defining the epidemiology of human papillomavirus infection and cervical neoplasia. , 1992, Journal of the National Cancer Institute.

[40]  K. Münger,et al.  The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[41]  E. Blackburn,et al.  Structure and function of telomeres , 1991, Nature.

[42]  Arnold J. Levine,et al.  The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 , 1990, Cell.

[43]  A. Levine,et al.  Association of human papillomavirus types 16 and 18 E6 proteins with p53. , 1990, Science.

[44]  G. Morin.  The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats , 1989, Cell.

[45]  K. Münger,et al.  The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. , 1989, Science.

[46]  O. Brison,et al.  Interferon modulation of c-myc expression in cloned Daudi cells: relationship to the phenotype of interferon resistance , 1986, Molecular and cellular biology.

[47]  E. Knight,et al.  Selective reduction of c-myc mRNA in Daudi cells by human beta interferon. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[48]  Y. Cong,et al.  The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter. , 1999, Human molecular genetics.

[49]  J. de Maeyer-Guignard,et al.  Type I interferons. , 1998, International reviews of immunology.

[50]  Gregg B. Morin,et al.  Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT , 1997, Nature Genetics.

[51]  N. Satoh,et al.  Common deleted region on the long arm of chromosome 5 in esophageal carcinoma. , 1996, Gastroenterology.

[52]  J. Shay,et al.  Telomerase activity in human germline and embryonic tissues and cells. , 1996, Developmental genetics.

[53]  A. Kimchi,et al.  Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the gamma interferon-induced cell death. , 1995, Genes & development.